Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.

作者: Oliver Cooper , Malin Parmar , Ole Isacson

DOI: 10.1016/B978-0-444-59575-1.00012-0

关键词: NeuroscienceParkinson's diseaseCell therapyBiologyCellular differentiationDopaminergicInduced pluripotent stem cellEmbryonic stem cellSomatic cellTransplantation

摘要: Human pluripotent stem cells provide new choices for sources of A9-type dopaminergic (DA) neurons in clinical trials neural transplantation patients with Parkinson's disease (PD). For example, "self" and HLA-matched A9 DA may improve the patient-to-patient variability observed previous using fetal obviate need long-term immunosuppression patient. Normal chromosomal structure minimal somatic mutations are necessary criteria assuring safe reproducible differentiated into PD trials. However, these cell source, application pluripotency assays as to ensure quality becomes less relevant. New more relevant standards control, assurance, function required. We suggest that assurance measures focus upon readouts authentic midbrain neurons, their integration growth vivo assays, functional stability.

参考文章(57)
O Lindvall, H Widner, H Widner, A Björklund, B Åstedt, R E Strecker, D J Clarke, Patrik Brundin, O G Nilsson, Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Experimental Brain Research. ,vol. 70, pp. 192- 208 ,(1988) , 10.1007/BF00271860
Ali H Brivanlou, Fred H Gage, Rudolf Jaenisch, Thomas Jessell, Douglas Melton, Janet Rossant, None, Setting Standards for Human Embryonic Stem Cells Science. ,vol. 300, pp. 913- 916 ,(2003) , 10.1126/SCIENCE.1082940
Paola Piccini, David J. Brooks, Anders Björklund, Roger N. Gunn, Paul M. Grasby, Ornella Rimoldi, Patrik Brundin, Peter Hagell, Stig Rehncrona, Håkan Widner, Olle Lindvall, Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient Nature Neuroscience. ,vol. 2, pp. 1137- 1140 ,(1999) , 10.1038/16060
Hiroshi Kawasaki, Kenji Mizuseki, Satomi Nishikawa, Satoshi Kaneko, Yoshihisa Kuwana, Shigetada Nakanishi, Shin-Ichi Nishikawa, Yoshiki Sasai, Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron. ,vol. 28, pp. 31- 40 ,(2000) , 10.1016/S0896-6273(00)00083-0
Jan Pruszak, Wesley Ludwig, Alexandra Blak, Kambiz Alavian, Ole Isacson, CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells. ,vol. 27, pp. 2928- 2940 ,(2009) , 10.1002/STEM.211
P. Sgado, L. Alberi, D. Gherbassi, S. L. Galasso, G. M. J. Ramakers, K. N. Alavian, M. P. Smidt, R. H. Dyck, H. H. Simon, Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 15242- 15247 ,(2006) , 10.1073/PNAS.0602116103
Dali Yang, Zhi-Jian Zhang, Michael Oldenburg, Melvin Ayala, Su-Chun Zhang, Human Embryonic Stem Cell-Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats Stem Cells. ,vol. 26, pp. 55- 63 ,(2008) , 10.1634/STEMCELLS.2007-0494
Gabriella L *Boulting, Evangelos *Kiskinis, Gist F *Croft, Mackenzie W *Amoroso, Derek H *Oakley, Brian J Wainger, Damian J Williams, David J Kahler, Mariko Yamaki, Lance Davidow, Christopher T Rodolfa, John T Dimos, Shravani Mikkilineni, Amy B MacDermott, Clifford J Woolf, Christopher E Henderson, Hynek Wichterle, Kevin Eggan, (*Co-First authors), None, A functionally characterized test set of human induced pluripotent stem cells Nature Biotechnology. ,vol. 29, pp. 279- 286 ,(2011) , 10.1038/NBT.1783
Sang-Hun Lee, Nadya Lumelsky, Lorenz Studer, Jonathan M. Auerbach, Ron D. McKay, Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells Nature Biotechnology. ,vol. 18, pp. 675- 679 ,(2000) , 10.1038/76536